Marea Therapeutics
CA - South SFBiotechnology
Focus: Marea Therapeutics is a pre-revenue biotech focused on cardiometabolic disease treatments, headquartered in South San Francisco with a public listing status. The company operates as a small, focused pipeline player in metabolic disease with early-stage clinical programs.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Marea Therapeutics?
AI assessmentMarea represents a high-risk, high-autonomy early-stage play suitable only for career builders comfortable with binary pipeline outcomes and wanting hands-on clinical development experience.
Why Work Here
- Early-stage opportunity to shape clinical development in underserved cardiometabolic space with MAR001 in Phase 2 for hypertriglyceridemia
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MAR002
AcromegalyClinical Trials (1)
NCT07195175Study of MAR002 in Healthy Men
Phase 1Help build intelligence for Marea Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.